SLC6A3 and Parkinson disease: Furthermore, to align with our aims of employing clinically feasible and easily implementable data for monitoring patients with PD in clinical settings, we restricted our analysis to basic clinical, cognitive, main genetic data and mutations and DAT imaging data.